跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATROVENT ipratropium bromide 250 micrograms/mL (as monohydrate) conventional inhalation bottle - TGA Drug Approval Details
Approvals
/
TGA
/
ATROVENT ipratropium bromide 250 micrograms/mL (as monohydrate) conventional inhalation bottle
Approved
STANDARD
ATROVENT ipratropium bromide 250 micrograms/mL (as monohydrate) conventional inhalation bottle
Boehringer Ingelheim Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c6f136938ab99ca0
Company
Boehringer Ingelheim Pty Ltd
Type
Standard
Approval Details
Approval Id
c6f136938ab99ca0
Product Name
ATROVENT ipratropium bromide 250 micrograms/mL (as monohydrate) conventional inhalation bottle
Artg Id
39953
Artg Name
ATROVENT ipratropium bromide 250 micrograms/mL (as monohydrate) conventional inhalation bottle
Sponsor
Boehringer Ingelheim Pty Ltd
Company Detail Path
/organization/boehringer-ingelheim-pty-ltd
Artg Date
1992-11-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b42c43669f3f8112e0e383611bee3325.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/78256f7630b8878891dbe21c3d7c4ce2.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c6f136938ab99ca0
Type
Standard
Back to TGA Approvals